Resultados de la búsqueda 81-90 of 15043 for Pancreatic+cancer

  1. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    ... pancreatic cancer patients. DISEASE STATE - Potentially operable or ... Borderline Resectable Pancreatic Cancer - Tumor-vessel interface ≥180° of ...

  2. Neurología - Ensayos clínicos - Mayo Clinic

    ... pancreatic cancer, (2-4) advanced, unresectable breast cancer (up to 6 donors per phenotype: triple negative [HER2, estrogen and progesterone receptor (ER ...

  3. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    TTF is currently under study for treatment of CNS parenchymal metastases, lung and pancreatic cancer. There is potential application for symptomatic ...

  4. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    ... Pancreatic SPORE, “Optimal Immunotargeting of MUC1 for Advanced Pancreatic Cancer” (Principal Investigator Dr. Gendler). Eligibility Criteria, keep current ...

  5. Neurología - Ensayos clínicos - Mayo Clinic

    ... Pancreatic SPORE, “Optimal Immunotargeting of MUC1 for Advanced Pancreatic Cancer” (Principal Investigator Dr. Gendler). Eligibility Criteria, keep current ...

  6. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    TTF is currently under study for treatment of CNS parenchymal metastases, lung and pancreatic cancer. There is potential application for symptomatic ...

  7. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    ... cancer). Also want to find out if kidney tumor treatment leads to an ... Pancreatic Cancer” (Principal Investigator Dr. Gendler). Eligibility ...

  8. Hematología - Ensayos clínicos - Mayo Clinic

    ... Pancreatic SPORE, “Optimal Immunotargeting of MUC1 for Advanced Pancreatic Cancer” (Principal Investigator Dr. Gendler). Eligibility Criteria, keep current ...

  9. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    TTF is currently under study for treatment of CNS parenchymal metastases, lung and pancreatic cancer. There is potential application for symptomatic ...

  10. Neurología - Ensayos clínicos - Mayo Clinic

    ... pancreatic cancer, (2-4) advanced, unresectable breast cancer (up to 6 donors per phenotype: triple negative [HER2, estrogen and progesterone receptor (ER ...